New ECDC guidance on the establishment and implementation of infection prevention and control programmes in healthcare
ESWI Activity Report for 2025
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
mRNA-1010 was superior to standard-dose licensed vaccines for prevention of RT-PCR–confirmed, protocol-defined influenza-like illness in adults 50 years of age or older. (Article for subscribers)
Progress and challenges in seasonal influenza vaccination across 54 countries and areas in the WHO European Region, 2008/09–2022/23: a repeated cross-sectional ecological study
Continued investment in national programmes is needed, especially in middle-income CA to keep increasing coverage among high-risk groups.
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial
In adults living with severe obesity, RIV elicited stronger short-term humoral immune responses than an egg-based standard-dose vaccine, suggesting potential additional benefit for influenza prevention in this vulnerable population.
Influenza vaccination attenuates acute myocardial infarction and stroke risk following influenza infection: a register-based, self-controlled case series study, Denmark, 2014 to 2025
Influenza infection conferred a transiently increased risk of first-time AMI and stroke. Vaccination substantially attenuated this risk, supporting its role in preventing cardiovascular complications after breakthrough infection.
Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models
Vaccine-induced immunity was consistent across species, supporting the translatability of the mouse model findings to cattle.
Highly Pathogenic Avian Influenza A(H5N1) Virus RNA in Bovine Semen, California, USA, 2024
Since March 2024, highly pathogenic avian influenza (HPAI) A(H5N1) virus has infected dairy cattle in the United States, prompting concern about novel transmission routes.